Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001127602-13-023069)

Filing Details

Accession Number:
0001127602-13-023069
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-07-17 18:17:36
Reporting Period:
2013-07-15
Filing Date:
2013-07-17
Accepted Time:
2013-07-17 18:17:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298861 M Trevor Jones 2525 Dupont Drive
Irvine CA 92612		 Yes No No No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-07-15 1,000 $51.72 12,142 No 4 M Direct
Common Stock Disposition 2013-07-15 2,000 $91.15 10,142 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Show Other Fields >>
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Nonemployee Director Stock Option (Right to Buy) Disposition 2013-07-15 1,000 $0.00 1,000 $51.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
7,000 2007-05-02 2016-05-02 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on November 22, 2012.
  2. Includes 6,942 shares of the Issuer's common stock underlying the RSUs awarded.
  3. Includes shares acquired pursuant to dividend equivalent rights attached to RSU previously granted to the Reporting Person.
  4. Option is fully vested and exercisable on the one year (1) year anniversary of its grant.